Wildtype’s 2025 FDA clearance opened U.S. restaurant sales, but high costs, small volumes and state bans stand between cultivated fish and wider distribution.
In June 2025, the Food and Drug Administration said it had no safety questions about Wildtype’s cell-cultivated coho salmon, making it the first cultivated seafood product to reach the U.S. market following FDA review. The fish reached menus at Kann in Portland, Oregon, and, beginning in July 2025, at Otoko in Austin, Texas.
The regulatory milestone addressed food safety, not commercial viability. Producers still need to demonstrate that growing fish cells in tanks can deliver products at prices and volumes that support a sustainable business.
Producers target high-value species first
Wildtype grows salmon cells in tanks at a pilot plant in a former San Francisco brewery. It says it began with a small cell sample from a juvenile Pacific salmon and no longer needs to harvest wild or farmed fish. The product is sold as sushi-grade salmon for raw preparations.
BlueNalu, based in San Diego, is developing cultivated bluefin tuna toro, the fatty belly cut used in sushi and sashimi. CEO Lou Cooperhouse says restaurants buying premium bluefin typically must source a whole fish, headed and gutted, while cultivated tissue lets the company target the toro alone.
BlueNalu says it aims to use a single cell type for the cut to keep production efficient. A Tokyo University report put Pacific bluefin at 2.6% of its historic unfished size. The appeal of premium species is economic: a high-value product may better absorb the costs of an emerging production process than lower-priced commodity seafood. That advantage, however, depends on whether manufacturers can bring those costs down.
BlueNalu and umami bioworks seek approvals abroad
BlueNalu said in March it expected FDA clearance for its tuna within weeks. It has also filed in Singapore, joined the U.K.’s regulatory sandbox and engaged with authorities in Japan, South Korea, Saudi Arabia and the European Union. Cooperhouse says Singapore is the furthest along.
Singapore-based Umami Bioworks registered two cultivated fish ingredients for pet food in the EU. It says the registration establishes a clear path to market, but the authorization applies to pet food, not products intended for human consumption..
Umami, which merged with Shiok Meats in 2024, has also developed cultivated eel and bluefin tuna for human consumption and held a public tasting of cultivated white fish and caviar in London. The U.K. Food Standards Agency has introduced a pilot service to help cultivated food companies seek approval.
Food and agriculture groups join funding rounds
Wildtype raised $100 million Series B in 2022, which was then described as the largest cultivated seafood financing on record. BlueNalu reports raising about $11 million to expand capacity. Cargill backs Wildtype, while BlueNalu’s investors include Nutreco, Sumitomo and Pulmuone.
Strategic investors can bring industry knowledge, supply-chain relationships and potential routes to market. Their participation, however, does not establish that cultivated seafood can be produced competitively or sold at scale. Those questions depend on manufacturing economics, demand and the capital required to expand production.
High costs and small volumes limit output
One industry estimate put the cost of producing a pound of Wildtype salmon at roughly $400,000 when development began in 2016. That figure illustrates the technology’s early-stage cost burden; it should not be read as a current production cost or as a measure of progress since then.
In 2022, BlueNalu described a planned pilot facility with capacity for 200 to 500 pounds of seafood a week. That output would support product development and restaurant trials, rather than the volumes required for broad grocery distribution. Cooperhouse has said the scaffold-free process could support bioreactors of up to 100,000 liters. The company had planned to begin building a commercial-scale facility in 2026.
Growth media, the nutrient mix that feeds the cells, is one cost lever. Clever Carnivore, a cultivated pork startup, says its in-house media costs $0.07 per liter at pilot scale, against a reported $1 to $10 per liter for leading products. Those figures are company-reported and relate to pork production, so they do not establish the cost of media for cultivated seafood or the economics of a commercial fish facility.
Scaling production will require more than lowering the cost of individual inputs. Companies must also finance facilities, maintain consistent yields, manage operating costs and produce enough volume to serve customers reliably. Whether investors will commit the capital needed for commercial-scale plants remains an open question.
Seven states ban cultivated meat sales
Florida, Alabama, Mississippi, Montana, Indiana, Nebraska and Texas have banned cultivated meat sales. Florida’s ban, signed in May 2024, was the first. Texas’ two-year ban took effect Sept. 1, 2025, with fines of up to $25,000 per day.
Wildtype and Upside Foods sued in federal court, arguing the Texas law violates constitutional commerce protections. A judge allowed the case to proceed in January 2026. In March, the 11th U.S. Circuit Court of Appeals upheld Florida’s ban against a challenge by Upside, ruling that federal law does not override a ban that does not regulate a producer’s ingredients, facilities or operations. The Florida ruling does not decide the separate legal challenge to Texas’ law. Texas Agriculture Commissioner Sid Miller called the decision to let the suit proceed an assault on ranchers.
The restrictions create a market-access problem for producers seeking national distribution. Little cultivated product was on sale in Texas when the law passed, and Otoko was then the only restaurant serving any. The broader risk for producers is fragmentation: differing state rules could complicate national distribution.
Grocery distribution could take 10 to 15 years
Industry experts estimate cultivated meat could take 10 to 15 years to appear widely in grocery stores. Although producers have worked to reduce costs, cultivated products remain significantly more expensive than conventionally produced meat and have not reached price parity. The timeline is an industry estimate, not a confirmed launch schedule.
Seafood companies are beginning with restaurants, where limited quantities and higher prices may be easier to accommodate than in mainstream retail.. BlueNalu plans a soft launch in San Diego before seeking wider distribution. Supporters say cultivated protein could reduce the environmental footprint, associated with conventional animal production, but its overall environmental performance depends on factors including energy use, production inputs and manufacturing efficiency.
For cultivated seafood, the next phase will test whether regulatory progress can translate into repeatable production, competitive pricing and dependable supply. FDA review has opened a route to market for Wildtype’s salmon, but wider commercial adoption will also depend on financing larger facilities, demonstrating demand and resolving legal challenges to state restrictions.
